Related references
Note: Only part of the references are listed.Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
Zhihui Wang et al.
BMC CANCER (2010)
Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients
Parvin Mehdipour et al.
CELL BIOLOGY INTERNATIONAL (2009)
Cancer-associated regulation of alternative splicing
Julian P. Venables et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Cell cycle dysregulation influences survival in high risk breast cancer patients
Robert Koenigsberg et al.
CANCER INVESTIGATION (2008)
Identification of Alternative Splicing Markers for Breast Cancer
Julian P. Venables et al.
CANCER RESEARCH (2008)
Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes
Jonathan S. Caudill et al.
LEUKEMIA & LYMPHOMA (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Differential mitotic degradation of the CDC25B phosphatase variants
I. Kieffer et al.
ONCOGENE (2007)
CDC25 phosphatases in cancer cells: key players? Good targets?
Rose Boutros et al.
NATURE REVIEWS CANCER (2007)
Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer
Serena Bonin et al.
VIRCHOWS ARCHIV (2006)
The when and wheres of CDC25 phosphatases
R Boutros et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Cdc25: mechanisms of checkpoint inhibition and recovery
Christina Karisson-Rosenthal et al.
TRENDS IN CELL BIOLOGY (2006)
Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer
M Ozen et al.
CLINICAL CANCER RESEARCH (2005)
Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma
JC Guo et al.
ONCOGENE (2004)
Cdc25 phosphatases and cancer
K Kristjánsdóttir et al.
CHEMISTRY & BIOLOGY (2004)
Splice variants as cancer biomarkers
BMN Brinkman
CLINICAL BIOCHEMISTRY (2004)
Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding
MS Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium
H Tsuda et al.
ONCOLOGY (2003)
Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
K Nishioka et al.
BRITISH JOURNAL OF CANCER (2001)
Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C
S Wegener et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2000)
Role of the Cdc25A phosphatase in human breast cancer
MG Cangi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
